 Tumor Lysis Syndrome
"Tumor Lysis Syndrome" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A syndrome resulting from cytotoxic therapy, occurring generally in aggressive, rapidly proliferating lymphoproliferative disorders. It is characterized by combinations of hyperuricemia, lactic acidosis, hyperkalemia, hyperphosphatemia and hypocalcemia.
| Descriptor ID |
D015275
|
| MeSH Number(s) |
C15.604.515.880 C20.683.515.950
|
| Concept/Terms |
Tumor Lysis Syndrome- Tumor Lysis Syndrome
- Syndrome, Tumor Lysis
- Syndromes, Tumor Lysis
- Tumor Lysis Syndromes
- Tumour Lysis Syndrome
- Syndrome, Tumour Lysis
- Syndromes, Tumour Lysis
- Tumour Lysis Syndromes
|
Below are MeSH descriptors whose meaning is more general than "Tumor Lysis Syndrome".
Below are MeSH descriptors whose meaning is more specific than "Tumor Lysis Syndrome".
This graph shows the total number of publications written about "Tumor Lysis Syndrome" by people in this website by year, and whether "Tumor Lysis Syndrome" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2001 | 1 | 0 | 1 | | 2004 | 1 | 0 | 1 | | 2014 | 1 | 0 | 1 | | 2019 | 0 | 1 | 1 | | 2023 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Tumor Lysis Syndrome" by people in Profiles.
-
Sawalha Y, Goyal S, Switchenko JM, Romancik JT, Kamdar M, Greenwell IB, Hess BT, Isaac KM, Portell CA, Mejia Garcia A, Goldsmith S, Grover NS, Riedell PA, Karmali R, Burkart M, Buege M, Akhtar O, Torka P, Kumar A, Hill BT, Kahl BS, Cohen JB. A multicenter analysis of the outcomes with venetoclax in patients with relapsed mantle cell lymphoma. Blood Adv. 2023 07 11; 7(13):2983-2993.
-
Ejaz AA, Mohandas R, Beaver TM, Johnson RJ. A Crystal-Independent Role for Uric Acid in AKI Associated with Tumor Lysis Syndrome. J Am Soc Nephrol. 2023 01 01; 34(1):175.
-
Jonas BA, Pollyea DA. How we use venetoclax with hypomethylating agents for the treatment of newly diagnosed patients with acute myeloid leukemia. Leukemia. 2019 12; 33(12):2795-2804.
-
Koratala A, Singhania G, Alquadan KF, Shimada M, Johnson RJ, Ejaz AA. Serum Uric Acid Exhibits Inverse Relationship with Estimated Glomerular Filtration Rate. Nephron. 2016; 134(4):231-237.
-
Ejaz AA, Pourafshar N, Mohandas R, Smallwood BA, Johnson RJ, Hsu JW. Uric acid and the prediction models of tumor lysis syndrome in AML. PLoS One. 2015; 10(3):e0119497.
-
Burns RA, Topoz I, Reynolds SL. Tumor lysis syndrome: risk factors, diagnosis, and management. Pediatr Emerg Care. 2014 Aug; 30(8):571-6; quiz 577-9.
-
Bercovitz RS, Greffe BS, Hunger SP. Acute tumor lysis syndrome in a 7-month-old with hepatoblastoma. Curr Opin Pediatr. 2010 Feb; 22(1):113-6.
-
Shimada M, Johnson RJ, May WS, Lingegowda V, Sood P, Nakagawa T, Van QC, Dass B, Ejaz AA. A novel role for uric acid in acute kidney injury associated with tumour lysis syndrome. Nephrol Dial Transplant. 2009 Oct; 24(10):2960-4.
-
Trobaugh-Lotrario AD, Liang X, Janik JS, Lovell MA, Odom LF. Difficult diagnostic and therapeutic cases: CASE 2. thymoma and tumor lysis syndrome in an adolescent. J Clin Oncol. 2004 Mar 01; 22(5):955-7.
-
Woo IS, Kim JS, Park MJ, Lee MS, Cheon RW, Chang HM, Ahn JS, Lee JA, Park YI, Park YS, Shim JW, Yang I. Spontaneous acute tumor lysis syndrome with advanced gastric cancer. J Korean Med Sci. 2001 Feb; 16(1):115-8.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|